Details
Stereochemistry | ACHIRAL |
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O
InChI
InChIKey=QAOWNCQODCNURD-UHFFFAOYSA-N
InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)
SULFATE (as sodium sulfate, potassium sulfate, and magnesium sulfate) is a component of SUPREP Bowel Prep Kit. It is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults. Sulfate salts provide sulfate anions, which are poorly absorbed. The osmotic effect of unabsorbed sulfate anions and the associated cations causes water to be retained within the gastrointestinal tract. SUPREP Bowel Prep Kit, when ingested with a large volume of water, produces copious watery diarrhea.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme. | 1992 Apr |
|
Dextran sulphate induces a PKC and actin independent internalisation of CD4. | 1994 Sep |
|
Two selectins converge on sulphate. Leukocyte adhesion. | 1996 Mar 1 |
|
Structure-activity relationship of heparan sulphate. | 1997 Nov |
|
Dopamine sulphate: an enigma resolved. | 1999 Apr |
|
Heparan sulphate. Regulation of growth factors in the mammary gland. | 2000 |
|
Magnesium sulphate for eclampsia: putting the evidence into clinical practice. | 2000 Jun |
|
Magnesium sulphate versus lytic cocktail for eclampsia. | 2001 |
|
[Magnesium sulphate in the treatment of ischemic-hypoxic neonatal encephalopathy]. | 2001 Mar-Apr |
|
Chondroitin sulphate proteoglycans in the CNS injury response. | 2002 |
|
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. | 2003 |
|
Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. | 2003 Apr |
|
Heparan sulphate N-sulphotransferase activity: reaction mechanism and substrate recognition. | 2003 Apr |
|
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. | 2003 Aug |
|
Intravenous magnesium sulphate in acute myocardial infarction--is the answer "MAGIC"? | 2003 Mar |
|
Characterization of the Herpesvirus saimiri Orf51 protein. | 2004 Aug 15 |
|
[The extracellular matrix of the central nervous system: chondroitin sulphate type proteoglycans and neural repair]. | 2004 May 1-15 |
|
Epidemiology of 377 patients with chemical burns in Guangdong province. | 2004 Sep |
|
A meta-analysis on intravenous magnesium sulphate for treating acute asthma. | 2005 Jan |
|
Heparan sulphate proteoglycans: the sweet side of development. | 2005 Jul |
|
Chondroitin sulphate: antioxidant properties and beneficial effects. | 2006 Dec |
|
[Magnesium sulphate for the management of preeclampsia]. | 2006 Jan |
|
The role of heparan sulphate proteoglycans in angiogenesis. | 2006 Jun |
|
Insights into the role of heparan sulphate in fibroblast growth factor signalling. | 2006 Jun |
|
Dietary acidification enhances phosphorus digestibility but decreases H+/K+-ATPase expression in rainbow trout. | 2006 Oct |
|
[Therapy of osteoarthritis crystalline glucosamine sulphate/a review of the clinical effcacy]. | 2007 |
|
Cholesterol sulfate as a potential inhibitor of hepatitis C virus NS3 helicase. | 2014 Apr |
Patents
Sample Use Guides
Split-Dose (2-Day) Regimen:
The evening before colonoscopy: dilute one bottle with water to a total volume of 16 oz. (up to the fill line) and drink the entire amount. Drink 32 ounces of water over the next hour.
Next morning: repeat both steps using the second bottle. Complete preparation at least 2 hours before colonoscopy or as directed by a physician.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CODEX ALIMENTARIUS (GSFA) |
INS-513
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 908
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 887
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
EPA PESTICIDE CODE |
78001
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
DEA NO. |
6552
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 879
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 951
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
JECFA EVALUATION |
INS-513
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 1093
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 1094
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
CFR |
21 CFR 184.1095
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 447
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 1132
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7664-93-9
Created by
admin on Fri Dec 15 15:58:24 GMT 2023 , Edited by admin on Fri Dec 15 15:58:24 GMT 2023
|
PRIMARY | |||
|
sulfuric acid
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
26836
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
SUB179543
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
1118
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
38965
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
C28191
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
DTXSID5029683
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
231-639-5
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
SULFURIC ACID
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
SUB45925
Created by
admin on Fri Dec 15 15:58:24 GMT 2023 , Edited by admin on Fri Dec 15 15:58:24 GMT 2023
|
PRIMARY | |||
|
248648
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
O40UQP6WCF
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
O40UQP6WCF
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
100000131607
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
1811
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
DB11309
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
m10374
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
10231
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL572964
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY | |||
|
C033158
Created by
admin on Fri Dec 15 15:58:25 GMT 2023 , Edited by admin on Fri Dec 15 15:58:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY